Micron Biomedical Secures Series A Financing To Commercialize Map Technology For Self-Administration Of Drugs And Vaccines Without Needles
Round Type
Series A
AtlantaBiotechnologyHealth CareInvestors
Description
Micron Biomedical, Inc. is a clinical stage life sciences company advancing its Micro Array Patch (MAP) technology for self-administration and simple, less-skilled caregiver administration of drugs and vaccines without needles. The $14 million Series A financing will support the company's development of commercial manufacturing, currently underway and establishes a strong partnership between Micron and LTS Lohmann. Micron's development pipeline includes vaccine and drug products partnered with pharma companies, foundations, and government agencies
Who to call at Micron Biomedical, and when
A new round usually means Micron Biomedical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Micron Biomedical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Micron Biomedical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Micron Biomedical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Micron Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMicron Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.